Treatment of Primary CNS Lymphoma ( FTD )

Clinical trial NCT05274139 · COMPLETED

Trial details

NCT number: NCT05274139
Sponsor: Mingzhi Zhang
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary CNS Lymphoma (PCNSL)

Start date: 2017-03-02
Primary completion: 2019-03-02
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.